Five, seven or ten? No – it’s not a trendy store for juniors… it is a real-life anti-estrogen treatment dilemma facing oncologists and their post-menopausal, ER+, early-stage, breast cancer patients. Standard of care is to take anti-estrogen treatment for at least the first 5 years after diagnosis to help prevent hormone-receptor positive breast cancer recurrences. […]
So what are the experts saying about anti-estrogen therapy for pre-menopausal patients diagnosed with breast cancer? Late last year, three dynamic oncologists from the University of Wisconsin, Madison – Amye Tevaarwerk, MD; Kari Wisinski, MD; and Ruth O’Regan, MD – collaborated to publish a review about the history and current state of anti-estrogen treatment. for […]
Fighting cancer can be complicated. Whether you are just beginning your journey to fight estrogen receptor positive (ER+) breast cancer or are approaching your 5 year anniversary and are wondering what’s next, you have options to consider and discuss with your healthcare team.
To help supplement the conversations with your physician, below, we have included some helpful information and links from trusted sources about each stage in your journey to fight early stage ER+ breast cancer.